Updated just now · Live
Stock analysis, price data, and AI-powered insights for Oric Pharmaceuticals Inc (ORIC).
Oric Pharmaceuticals Inc operates in the Biotechnology sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for ORIC.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). ORIC Stock Intelligence Report. [stoxpulse.com/stocks/oric]
Disclaimer: The information on this page about Oric Pharmaceuticals Inc (ORIC) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Oric Pharmaceuticals Inc.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
ORIC Pharmaceuticals Presents Multiple Poster Pres...
4d ago
ORIC® Pharmaceuticals Presents Preclinical Data to...
4d ago
StoxPulse AI results for ORIC: Pulse Score 54/100. Primary sentiment trends from 2 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$1.09B
P/E Ratio
—
EPS
$-0.33
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
ORIC Pharmaceuticals Presents Multiple Poster Presentation At 2026 American Association For Cancer Research Annual Meeting On Potential Of Rinzimetostat For Prostate Cancer Treatment
ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Research (AACR) Annual Meeting